Serial positron emission tomography fused to magnetic resonance imaging showed progression of GAD65 autoimmune encephalitis.
References
[1]
Vacchiano, V., Giannoccaro, M.P., Napolitano, R.P., Liguori, R., Allegri, V., Rinaldi, R., et al. (2019) Combined Brain Positron Emission Tomography/Magnetic Resonance Imaging in GABAA Receptor Encephalitis. European Journal of Neurology, 26. https://doi.org/10.1111/ene.14004
[2]
Coughlin, J.M., Yang, T., Rebman, A.W., Kortte, K.B., Du, Y., Mathews, W.B., et al. (2018) Imaging Glial Activation in Patients with Post-Treatment Lyme Disease Symptoms: A Pilot Study Using [11C]DPA-713 PET. Journal of Neuroinflammation, 15, 346. https://doi.org/10.1186/s12974-018-1381-4
[3]
Probasco, J.C., Solnes, L., Nalluri, A., Cohen, J., Jones, K.M., Zan, E., et al. (2017) Abnormal Brain Metabolism on FDG-PET/CT Is a Common Early Finding in Autoimmune Encephalitis. Neuroimmunology & Neuroinflammation, 4, e352.
https://doi.org/10.1212/NXI.0000000000000352
[4]
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M.R. and Balice-Gordon, R. (2011) Clinical Experience and Laboratory Investigations in Patients with Anti-NMDAR Encephalitis. The Lancet Neurology, 10, 63-74.
https://doi.org/10.1016/S1474-4422(10)70253-2
[5]
McKeon, A. and Tracy, J.A. (2017) GAD65 Neurological Autoimmunity. Muscle & Nerve, 56, 15-27. https://doi.org/10.1002/mus.25565
[6]
Bien, C.G., Vincent, A., Barnett, M.H., Becker, A.J., Blümcke, I., Graus, F., et al. (2012) Immunopathology of Autoantibody-Associated Encephalitides: Clues for Pathogenesis. Brain, 135, 1622-1638. https://doi.org/10.1093/brain/aws082
[7]
Graus, F., Titulaer, M.J., Balu, R., Benseler, S., Bien C.G., et al. (2016). A Clinical Approach to Diagnosis of Autoimmune Encephalitis. The Lancet Neurology, 15, 391-404. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066574/
